If you’ve been considering Roux-en-Y Gastric Bypass (RYGB) for weight loss, you might wonder how effective it is in the long run. A recent study looked at patients who had the surgery between 2008 and 2009 and followed them for up to 15 years. Here’s what they found, with insights from Dr. Alexander Abkin, a bariatric surgeon from New Jersey.

Long-Term Weight Loss

The study included 264 patients, mostly women, and assessed how well they maintained weight loss over 15 years. The results were promising. On average, patients lost about 31.5% of their total body weight in the first year, and they managed to keep losing more than 20% of their body weight throughout the follow-up period.

Dr. Abkin explains, “Roux-en-Y Gastric Bypass is known for its effectiveness in the short term, but this study really shows its long-term potential. Patients can maintain significant weight loss over many years, which is crucial for long-term success.”

Improvement in Health Conditions

The surgery didn’t just help with weight loss—it also improved several obesity-related health conditions. For example, about 61% of patients saw their type 2 diabetes go into remission, 47% saw improvements in their cholesterol levels, and 40% had their high blood pressure resolved. However, some conditions did return over time, with 24% of patients experiencing a return of diabetes and 18% seeing their high blood pressure come back.

Dr. Abkin adds, “One of the great benefits of Roux-en-Y Gastric Bypass is its ability to significantly improve or resolve health conditions related to obesity. However, it’s important to keep monitoring and managing these conditions, as some patients might experience a recurrence.”

Challenges and Considerations

The study also noted that about 51% of patients saw some weight regain over 15 years. Factors like higher initial body mass index and having type 2 diabetes before the surgery were linked to a higher chance of weight regain.

Dr. Abkin advises, “While Roux-en-Y Gastric Bypass can offer lasting results, it’s not a cure-all. Maintaining weight loss and health improvements requires ongoing effort and regular check-ups. Understanding the factors that contribute to weight regain can help in managing and overcoming these challenges.”

Conclusion

Overall, the study confirms that laparoscopic Roux-en-Y Gastric Bypass offers significant and lasting benefits for weight loss and improving obesity-related health conditions. Dr. Abkin sums it up: “Roux-en-Y Gastric Bypass remains a promising option for long-term weight management and health improvement. For those considering this surgery, it’s important to be aware of both its benefits and the need for long-term commitment to maintain results.”

This research highlights the effectiveness of Roux-en-Y Gastric Bypass over a lengthy period, offering valuable insights for anyone looking into weight loss surgery options.

Heart disease has held the title of the world’s leading cause of death for over a century. Unfortunately, the future does not seem to offer any relief from this statistic. Read more

As the demand for weight loss medications surges, the availability of Zepbound, manufactured by Eli Lilly, faces significant shortages, with no immediate solution in sight. The FDA approved Zepbound in November, offering a new option for weight loss alongside Novo Nordisk’s Wegovy. However, despite earlier assurances from Lilly’s CEO, Dave Ricks, shortages have become widespread just months after approval. Read more

New research sheds light on the effectiveness of gastric bypass surgery in maintaining remission of type 2 diabetes, even if patients regain weight over time. Dr. Alexander Abkin, a leading bariatric surgeon in New Jersey, helps break down the findings for us. Read more

A recent study published in the Journal of the American College of Cardiology found that people who have obesity often struggle with high blood pressure. However, those who undergo weight loss surgery, called bariatric surgery, tend to have better results in lowering their blood pressure compared to those who only rely on medication.” Read more